1. Home
  2. VHC vs MXCT Comparison

VHC vs MXCT Comparison

Compare VHC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$18.04

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.24

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
MXCT
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
93.0M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
VHC
MXCT
Price
$18.04
$1.24
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
12.7K
1.2M
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
N/A
EPS
N/A
N/A
Revenue
$162,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
N/A
52 Week Low
$6.60
$0.64
52 Week High
$29.00
$2.40

Technical Indicators

Market Signals
Indicator
VHC
MXCT
Relative Strength Index (RSI) 67.08 73.83
Support Level $15.94 $0.72
Resistance Level $18.32 $1.75
Average True Range (ATR) 1.12 0.10
MACD 0.48 0.02
Stochastic Oscillator 100.00 95.88

Price Performance

Historical Comparison
VHC
MXCT

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: